Sign in Pull a receipt

BDSX

BIODESIX INC

Healthcare · Diagnostics & Research

$288.97 sample

-4.02 (-1.37%) 1D

Market cap

$691.2B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-13

Alerts

8

Price$288.97 +10.48% 3M daily closessample

302.30258.15

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 22INSInsider sell: Chief Financial Officer
Oct 13SEC10-Q filed
Oct 05INSInsider sell: EVP, Operations
Sep 30INSInsider buy: Chief Executive Officer
Sep 23INSInsider sell: General Counsel
Sep 16INSInsider buy: 10% owner
Sep 09INSInsider buy: General Counsel
Sep 01INSInsider sell: 10% owner

Sign up to see the real BDSX record →

Company facts

SEC EDGAR registration

Name: BIODESIX INC
Sector: Healthcare
Industry: Diagnostics & Research
Smart-money score: +52sample, -100 to +100
Reporting currency: USD

Who is positioning in BDSX

sample

Insiders: 7 insider transactions over 90 days, net selling, $608.2M
Congress: No member trades over 90 days
Institutions · 13F: 39 funds hold $11.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$26.8B +19.5% y/y

Q4 2024Q3 2026

Inventory$16.3B +20.1% y/y

Q4 2024Q3 2026

Accounts receivable$11.6B +4.8% y/y

Q4 2024Q3 2026

Total debt$31.9B +13.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $352.9B +16.3% 3M
Sample peer B: $488.7B -0.2% 3M
Sample peer C: $246.5B +1.5% 3M
Sample peer D: $464.2B -5.8% 3M
Sample peer E: $499.3B +12.9% 3M